Note 2 - Acquisitions (Tables)

6 Months Ended

Dec. 31, 2014

	Novus		ProteinSimple		CyVek

Current assets	$	10,739	$	20,273	$	633
Equipment		1,266		1,983		980
Other long-term assets		40		554		19
Intangible Assets:
Developed technology		5,010		41,200		20,200
Trade name		5,300		36,300		100
Customer relationships		14,400		101,100		900
Non-compete agreements		0		200		0
Goodwill		26,692		133,015		99,870
Total assets acquired		63,447		334,625		122,702

Liabilities		2,166		11,304		1,913
Deferred income taxes, net		1,159		23,268		7,562
Net assets	$	60,122	$	300,053	$	113,227
Less fair-value of previous investment		0		0		18,300
Net assets acquired		60,122		300,053		94,927

Cash paid, net of cash acquired	$	60,122	$	300,053		59,927
Contingent consideration payable		0		0		35,000
Net purchase price	$	60,122	$	300,053	$	94,927

	Novus						ProteinSimple					CyVek
	Quarter Ended			Six Months Ended			Quarter Ended		Six Months Ended			Quarter Ended			Six Months Ended
	December 31, 2014			December 31, 2014			December 31, 2014		December 31, 2014			December 31, 2014			December 31, 2014

Net sales	$	5,112		$	10,593		$	20,099	$	33,013		$	200		$	200
Net (loss) income		(155	)		(354	)		595		(1,208	)		(1,023	)		(1,023	)
Amortization expense		429			949			3,194		5,374			251			251
Cost recognized on sale of acquired inventory		512			1,059			0		1,444			64			64